MiNK Therapeutics, Inc. (INKT)
9.57
-0.65
(-6.40%)
USD |
NASDAQ |
Nov 12, 16:00
9.57
0.00 (0.00%)
After-Hours: 18:41
MiNK Therapeutics Market Cap : 48.78M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 11, 2026 | 52.11M |
| November 10, 2026 | 51.02M |
| November 09, 2026 | 52.47M |
| November 06, 2026 | 52.75M |
| November 05, 2026 | 51.22M |
| November 04, 2026 | 54.03M |
| November 03, 2026 | 54.99M |
| November 02, 2026 | 56.27M |
| October 30, 2026 | 53.67M |
| October 29, 2026 | 55.43M |
| October 28, 2026 | 55.04M |
| October 27, 2026 | 54.18M |
| October 26, 2026 | 53.16M |
| October 23, 2026 | 54.59M |
| October 22, 2026 | 51.27M |
| October 21, 2026 | 54.13M |
| October 20, 2026 | 50.25M |
| October 19, 2026 | 48.72M |
| October 16, 2026 | 47.96M |
| October 15, 2026 | 50.66M |
| October 14, 2026 | 52.75M |
| October 13, 2026 | 52.14M |
| October 12, 2026 | 53.67M |
| October 09, 2026 | 54.64M |
| October 08, 2026 | 56.06M |
| Date | Value |
|---|---|
| October 07, 2026 | 58.20M |
| October 06, 2026 | 59.63M |
| October 05, 2026 | 62.18M |
| October 02, 2026 | 63.40M |
| October 01, 2026 | 64.88M |
| September 30, 2026 | 63.96M |
| September 29, 2026 | 62.49M |
| September 28, 2026 | 61.72M |
| September 25, 2026 | 62.08M |
| September 24, 2026 | 62.69M |
| September 23, 2026 | 62.94M |
| September 22, 2026 | 61.72M |
| September 21, 2026 | 62.43M |
| September 18, 2026 | 61.42M |
| September 17, 2026 | 59.68M |
| September 16, 2026 | 59.07M |
| September 15, 2026 | 58.15M |
| September 14, 2026 | 61.01M |
| September 11, 2026 | 61.16M |
| September 10, 2026 | 61.82M |
| September 09, 2026 | 60.65M |
| September 08, 2026 | 58.36M |
| September 04, 2026 | 59.33M |
| September 03, 2026 | 57.24M |
| September 02, 2026 | 57.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.132B |
| Alnylam Pharmaceuticals, Inc. | 20.96B |
| Anika Therapeutics, Inc. | 185.37M |
| Savara, Inc. | 968.08M |
| Vericel Corp. | 2.930B |
Market Cap Related Metrics
| Price | 9.57 |
| Earnings Yield | -25.05% |